LGL Partners’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.6M Buy
206,341
+4,591
+2% +$184K 3.15% 8
2026
Q1
$7.31M Buy
201,750
+10,041
+5% +$385K 3.01% 9
2025
Q4
$7.39M Buy
191,709
+1,545
+0.8% +$58.1K 3.15% 8
2025
Q3
$6.9M Buy
190,164
+3,962
+2% +$138K 2.94% 10
2025
Q2
$6.34M Buy
186,202
+21,794
+13% +$691K 2.81% 10
2025
Q1
$5.15M Sell
164,408
-83,878
-34% -$2.74M 2.48% 10
2024
Q4
$7.94M Buy
248,286
+15,849
+7% +$515K 1.15% 13
2024
Q3
$7.58M Buy
232,437
+49,792
+27% +$1.57M 1.06% 13
2024
Q2
$5.67M Buy
182,645
+52,009
+40% +$1.55M 0.83% 14
2024
Q1
$3.88M Buy
+130,636
New +$3.7M 0.65% 19

Other funds holding QLTY

LGL Partners's QLTY Position: Q2 2026 in Review

LGL Partners increased its GMO US Quality ETF (QLTY) stake by 2.3% in Q2 2026, buying an estimated $184K and bringing the position to 206,341 shares worth $8.6M. The position accounts for 3.15% of the portfolio, ranked #8.

LGL Partners first reported a position in QLTY in Q1 2024 and has held it in 10 quarters since. 70 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • LGL Partners held 206,341 shares of GMO US Quality ETF worth $8.6M as of Q2 2026.
  • LGL Partners bought 4,591 GMO US Quality ETF shares in Q2 2026, an estimated $184K.
  • GMO US Quality ETF made up 3.15% of LGL Partners's portfolio in Q2 2026, its #8 holding.
  • LGL Partners first reported a position in GMO US Quality ETF in Q1 2024 and has held it in 10 quarters since.
  • 70 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on LGL Partners's 13F filing for Q2 2026, filed 27 Jul 2026.